The Office of Technology Transfer (OTT) implemented office-wide efforts in recycling, energy reduction and creating a paperless office. OTT procured recycling bins for paper, batteries, mail packages, printer toner, glass and plastic. When drafting documents, the office uses old paper and, when possible, prints on both sides of the paper before recycling. During the most recent office renovation, OTT installed motion-sensing light switches to all its renovated office spaces. 

Abnormal T lymphocyte (T cell) function, including tumor formation in T cells, can lead to a wide variety of diseases. Over 100 million people worldwide suffer from T cell autoimmune disorders of varying severity, such as lupus and graft-versus-host disease, and the incidence of T cell-mediated cancers, including lymphomas and leukemias, has risen over the past decade. These diseases can be deadly, and not all patients respond to standard therapies.

The STEM Award recognizes the efforts of an FLC laboratory employee or team that has demonstrated outstanding work in support of science, technology, engineering, and mathematics (STEM) education during the past year. 

Most people are aware that anti-cancer treatments often have negative side effects, but patients are willing to tolerate these side effects for the potential life-saving effects of the treatment. However, some patients treated with the anti-cancer drug 5-Fluorouracil (5-FU) will have fatal reactions typically caused by cardiotoxicity. A life-saving diagnostic test to identify cancer patients who may experience 5-FU toxicity has been developed by scientists at the National Cancer Institute (NCI).